Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2008-8-15
pubmed:abstractText
To study the interactions of the heat shock protein 90 (HSP90) inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) and carboplatin in vitro and in vivo.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0344-5704
pubmed:author
pubmed:issnType
Print
pubmed:volume
62
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
769-78
pubmed:meshHeading
pubmed-meshheading:18193424-Animals, pubmed-meshheading:18193424-Antineoplastic Agents, pubmed-meshheading:18193424-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:18193424-Benzoquinones, pubmed-meshheading:18193424-Blotting, Western, pubmed-meshheading:18193424-Carboplatin, pubmed-meshheading:18193424-Cell Line, Tumor, pubmed-meshheading:18193424-Female, pubmed-meshheading:18193424-HSP90 Heat-Shock Proteins, pubmed-meshheading:18193424-Humans, pubmed-meshheading:18193424-Lactams, Macrocyclic, pubmed-meshheading:18193424-Mice, pubmed-meshheading:18193424-Mice, Nude, pubmed-meshheading:18193424-Ovarian Neoplasms, pubmed-meshheading:18193424-Rhodamines, pubmed-meshheading:18193424-Tetrazolium Salts, pubmed-meshheading:18193424-Thiazoles, pubmed-meshheading:18193424-Xenograft Model Antitumor Assays
pubmed:year
2008
pubmed:articleTitle
An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models.
pubmed:affiliation
Cancer Research UK Centre for Cancer Therapeutics, Haddow Laboratories, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't